The National Primary Health Care Development Agency (NPHCDA) said yesterday that Lagos, Ogun, Oyo, Jigawa and Osun were the top five leading with high uptake and also contributed 36 per cent to the number of vaccinated persons.
Executive Director, NPHCDA Dr. Faisal Shuaib stated this in an interview with the News Agency of Nigeria (NAN) yesterday in Abuja, while providing an update on the country’s vaccination campaign.
Shuaib said almost 10 million eligible persons have been fully vaccinated against the ongoing COVID-19 pandemic in the country.
“As of December 26, 2021, in 36 states and the FCT, 9,765,729 eligible persons targetted for COVID-19 vaccination received the first dose, while 4,363,620 got the second dose (fully vaccinated),” he stated.
The immunisation boss added that the proportion of eligible people vaccinated in the country for their first dose were 8.7 per cent, while the proportion of eligible people vaccinated for their second dose were 3.9 per cent as of Dec. 24, 2021.
He said Nasarawa State reclaimed its centre-stage position from Jigawa State after 48 hours in the COVID-19 mass vaccination campaign.
Shuaib said Jigawa State recently took the lead by displacing Nasarawa state, only for a turnaround in less than 48 hours.
The NPHCDA boss added that Zamfara, Delta and Cross River states have also made great strides towards joining the top five performing states as of yesterday.
He explained that vaccines were the best way to protect people from coronavirus and would save thousands of lives.
“Three vaccines have now been approved for use in the Nigeria and the government has secured early access to more vaccine doses.
“The Nigeria COVID-19 vaccine rollout is a big vaccination programme in history. The goal remains to vaccinate as many people as quickly as possible,” he added.
According to him, the NPHCDA aims to provide advice and information at every possible opportunity to support those getting the vaccine and to anyone who might have questions about the vaccination process.
Shuaib said the agency website also provide guidelines for persons that have completed two doses of AstraZeneca, Moderna, Pfizer Bio-NTech or one dose of Johnson & Johnson vaccine.